MD

Mahendra Dhulabhai Patel

Active Director Director DIN 09176499
DIN 09176499 First appointment May 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value •••• Premium profile

About Mahendra Dhulabhai Patel

Data last updated:

Mahendra Dhulabhai Patel is a Director at Dr. Vetrx Pharma Private Limited (since 2021). The company operates in Healthcare. Dr. Vetrx Pharma Private Limited reported revenue of ₹1.77 Cr (FY 2024).

DIN 09176499
Primary Designation Director
Industry Healthcare
First Appointment 17 May 2021
Oldest Company Age 5 yrs
Largest company Dr. Vetrx Pharma Private Limited · ₹1.77 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr. Vetrx Pharma Private Limited U51909GJ2021PTC122658
Director17 May 20212021₹1.77 Cr (FY 2024)Active

Board colleagues of Mahendra Dhulabhai Patel

NameDINCompanyDesignation
Ankit Jayantibhai Patel11219680Dr. Vetrx Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dr. Vetrx Pharma Private Limited
Premium access

Shareholding and investment profile for Mahendra Dhulabhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahendra Dhulabhai Patel

Mahendra Dhulabhai Patel currently holds 1 directorship: Dr. Vetrx Pharma Private Limited (Director, since 17 May 2021, revenue ₹1.77 Cr (FY 2024)).

Mahendra Dhulabhai Patel was first appointed on 17 May 2021 as Director at Dr. Vetrx Pharma Private Limited.

The current boards of Mahendra Dhulabhai Patel's companies include Ankit Jayantibhai Patel (Dr. Vetrx Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available